Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to establish safety and feasibility of intracerebral delivery of GCase via MRgFUS. This technique may offer potential benefits given the exposure of the putamen to GCase in animal models has been shown to be efficacious in improving Parkinson's disease pathology and phenotype.


Clinical Trial Description

This is a two-arm, open-label, intervention only phase I/II clinical study. One arm of the study will enroll seven (7) GBA PD patients and the other arm seven (7) idiopathic PD patients. During the intervention phase, the first four subjects of each arm will receive three transcranial bilateral putamenal GCase at 30 IU/kg IV every two weeks, followed by 60 IU/kg in the next three subjects. Following three treatments in this study, the subjects will be followed for twelve months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05565443
Study type Interventional
Source InSightec
Contact Nadir Alikacem
Phone +12146302000
Email nadira@insightec.com
Status Recruiting
Phase N/A
Start date November 30, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT01941732 - Motor Response to Sildenafil in PD Phase 4
Active, not recruiting NCT04777331 - A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease Phase 2
Completed NCT02452125 - The Effects of Nicotine Chewing Gum in Parkinson's Disease N/A
Completed NCT02569021 - Battery-preserving Stimulation Patterns for Deep Brain Stimulation N/A
Completed NCT02676804 - Exercise Dosing Trial for Individuals With Parkinson's Disease N/A
Completed NCT02092181 - A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) Phase 4
Terminated NCT02249559 - Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease N/A
Completed NCT01163344 - Dance Exercise as Novel Complementary Therapy for Parkinson's Disease N/A
Recruiting NCT05539196 - A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Completed NCT02318927 - A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease N/A
Active, not recruiting NCT01417598 - BETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical Activity N/A
Withdrawn NCT01256905 - Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies N/A
Completed NCT01789385 - Anesthesia for Deep Brain Stimulation Phase 4
Completed NCT01360229 - Acupuncture for Fatigue in Parkinson's Disease N/A
Recruiting NCT02126475 - Temporal Expectations in Parkinson's Disease N/A